Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19
NCT04930757 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-06-18
Summary
The main objective is to quantify the population of reverse migrating neutrophils in patients with COVID-19.
Conditions
- Covid19
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Hafid AIT-OUFELLA, Professor · Assistance Publique - Hôpitaux de Paris
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-04
- Primary Completion
- 2022-02-28
- Completion
- 2022-04-30
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome
NCT04346017 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Assessment of Peripheral Blood and Tissue Myeloid Cells. Phenotype for Precision Medicine in Patients With SARS-Cov-2 Infection
NCT05767853 ·Status: UNKNOWN
-
Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)
NCT05125887 ·Status: UNKNOWN
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients
NCT05089110 ·Status: UNKNOWN
-
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
NCT04904692 ·Status: ACTIVE_NOT_RECRUITING
-
Differential Diagnostics of Etiology of Acute Infections
NCT03161951 ·Status: COMPLETED
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Study of COVID-19 Prognostic Factors in Hospitalized Patients
NCT05102708 ·Status: COMPLETED
-
Observational Cohort of COVID-19 Patients at Raymond-Poincare
NCT04364698 ·Status: UNKNOWN
-
poSt Covid-19 Infection centraL Sensitisation 2
NCT04701892 ·Status: UNKNOWN
-
Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)
NCT04402905 ·Status: COMPLETED
-
Monocytes and NK Cells Activity in Covid-19 Patients
NCT04375176 ·Status: UNKNOWN
-
Myeloid Cells in Patients With Covid-19 Pneumonia
NCT04590261 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
NCT04668170 ·Status: COMPLETED
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
Immune Cells Phenotypes During COVID-19
NCT04816760 ·Status: UNKNOWN
-
Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)
NCT04703114 ·Status: COMPLETED ·Phase: NA
-
Retrospective and Prospective Cohort of Patients Entering the Multidisciplinary Management of Post-Covid Syndromes
NCT05805566 ·Status: RECRUITING
-
Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study
NCT04365764 ·Status: COMPLETED
-
COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study
NCT04385069 ·Status: UNKNOWN
-
Microecology and Host Immunity in Patients With Severe COVID-19 Infection
NCT05670275 ·Status: UNKNOWN
-
Study of Virus-specific Lymphocytic Cell Populations in Non-invasive Nasal Mucosa Samples of MIS-C Patients
NCT05560906 ·Status: UNKNOWN
-
Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study
NCT04903834 ·Status: UNKNOWN